University of Chicago Medical Center Univ Chicago

Chicago, Illinois 60637

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials